Fellowship Training in Arthroplasty Improves Treatment Success of Debridement, Antibiotics, and Implant Retention for Periprosthetic Knee Infections.

DAIR Fellowship training Periprosthetic infection

Journal

Arthroplasty today
ISSN: 2352-3441
Titre abrégé: Arthroplast Today
Pays: United States
ID NLM: 101681808

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 14 06 2023
revised: 19 02 2024
accepted: 12 03 2024
medline: 27 6 2024
pubmed: 27 6 2024
entrez: 27 6 2024
Statut: epublish

Résumé

Debridement, antibiotics, and implant retention (DAIR) is a well-accepted surgical strategy for periprosthetic joint infection (PJI) following total knee arthroplasty (TKA). DAIR in TKA may be incorrectly thought of as a "simple" procedure not requiring formal specialized training in arthroplasty. Currently, there are no studies comparing the risk of treatment failure based on surgeon fellowship training. A retrospective review was performed of consecutive patients who underwent DAIR for TKA PJI at our institution. Two cohorts were created based on whether DAIR was performed by an arthroplasty fellowship-trained (FT) surgeon or nonarthroplasty fellowship-trained (NoFT) surgeon. Primary outcome was treatment failure following DAIR at a minimum of 1 year postoperatively. Treatment failure was based on the Tier 1 International Consensus Meeting definition of infection control. Secondary outcomes were also recorded including death during the totality of PJI treatment. A total of 112 patients were identified (FT = 68, NoFT = 44). At a mean follow-up of 7.3 years [standard deviation = 3.9], 73 patients (59.8%) failed treatment. Fellowship training in arthroplasty significantly improved treatment success rates (FT, 35/68 [51.5%]; NoFT, 10/44 [22.7%]; odds ratio 2.5 [95% confidence interval 1.1 to 5.9; TKA PJI treated with DAIR should not be considered a simple procedure. Improved treatment success may be associated with subspecialty fellowship training in arthroplasty. IV.

Sections du résumé

Background UNASSIGNED
Debridement, antibiotics, and implant retention (DAIR) is a well-accepted surgical strategy for periprosthetic joint infection (PJI) following total knee arthroplasty (TKA). DAIR in TKA may be incorrectly thought of as a "simple" procedure not requiring formal specialized training in arthroplasty. Currently, there are no studies comparing the risk of treatment failure based on surgeon fellowship training.
Methods UNASSIGNED
A retrospective review was performed of consecutive patients who underwent DAIR for TKA PJI at our institution. Two cohorts were created based on whether DAIR was performed by an arthroplasty fellowship-trained (FT) surgeon or nonarthroplasty fellowship-trained (NoFT) surgeon. Primary outcome was treatment failure following DAIR at a minimum of 1 year postoperatively. Treatment failure was based on the Tier 1 International Consensus Meeting definition of infection control. Secondary outcomes were also recorded including death during the totality of PJI treatment.
Results UNASSIGNED
A total of 112 patients were identified (FT = 68, NoFT = 44). At a mean follow-up of 7.3 years [standard deviation = 3.9], 73 patients (59.8%) failed treatment. Fellowship training in arthroplasty significantly improved treatment success rates (FT, 35/68 [51.5%]; NoFT, 10/44 [22.7%]; odds ratio 2.5 [95% confidence interval 1.1 to 5.9;
Conclusions UNASSIGNED
TKA PJI treated with DAIR should not be considered a simple procedure. Improved treatment success may be associated with subspecialty fellowship training in arthroplasty.
Level of Evidence UNASSIGNED
IV.

Identifiants

pubmed: 38933043
doi: 10.1016/j.artd.2024.101378
pii: S2352-3441(24)00063-3
pmc: PMC11200284
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101378

Informations de copyright

© 2024 The Authors.

Auteurs

Nicholas Tubin (N)

Division of Orthopaedic Surgery, Department of Orthopaedic Surgery, The Ottawa Hospital, Ottawa, ON, Canada.

Jonathan Brouget-Murray (J)

Division of Orthopaedic Surgery, Department of Orthopaedic Surgery, The Ottawa Hospital, Ottawa, ON, Canada.

Antoine Bureau (A)

Division of Orthopaedic Surgery, Department of Orthopaedic Surgery, The Ottawa Hospital, Ottawa, ON, Canada.

Jared Morris (J)

Division of Orthopaedic Surgery, Department of Orthopaedic Surgery, The Ottawa Hospital, Ottawa, ON, Canada.

Marsa Azad (M)

Division of Orthopaedic Surgery, Department of Orthopaedic Surgery, The Ottawa Hospital, Ottawa, ON, Canada.
Division of Orthopaedic Surgery, Department of Infectious Diseases, The Ottawa Hospital, Ottawa, ON, Canada.

Hesham Abdelbary (H)

Division of Orthopaedic Surgery, Department of Orthopaedic Surgery, The Ottawa Hospital, Ottawa, ON, Canada.

George Grammatopoulos (G)

Division of Orthopaedic Surgery, Department of Orthopaedic Surgery, The Ottawa Hospital, Ottawa, ON, Canada.

Simon Garceau (S)

Division of Orthopaedic Surgery, Department of Orthopaedic Surgery, The Ottawa Hospital, Ottawa, ON, Canada.

Classifications MeSH